VSee Health (NASDAQ:VSEE) vs. Phreesia (NYSE:PHR) Critical Comparison

Phreesia (NYSE:PHR) and VSee Health (NASDAQ:VSEE) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Phreesia and VSee Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	9	9	0	2.42
VSee Health	1	0	0	0	1.00

Phreesia currently has a consensus target price of $16.65, indicating a potential upside of 45.03%. Given Phreesia’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Phreesia is more favorable than VSee Health.

Insider & Institutional Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 1.0% of VSee Health shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Comparatively, 14.9% of VSee Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Phreesia and VSee Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
VSee Health	-92.36%	-11,636.34%	-68.62%

Valuation and Earnings

This table compares Phreesia and VSee Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59 million	1.48	$2.31 million	$0.15	76.52
VSee Health	$14.62 million	N/A	-$14.71 million	($0.54)	-0.09

Phreesia has higher revenue and earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Summary

Phreesia beats VSee Health on 11 of the 12 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About VSee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.